a Layered double hydroxide (LDH)-based nanocomposites, constructed by interacting LDH nanoparticles with other nanomaterials (e.g. silica nanoparticles and magnetic nanoparticles) or polymeric molecules (e.g. proteins), are an emerging yet active area in healthcare, environmental remediation, energy conversion and storage.
Introduction
Recent developments in material chemistry and nanotechnology have enabled scientists to develop various nanocomposites by combining different nanomaterials or modifying nanomaterials with functional molecules. The synthesised nanocomposites possess appealing and unique properties that render them attractive for application in healthcare, environmental remediation, and energy storage and conversion. [1] [2] [3] [4] [5] [6] [7] Building tailored layered double hydroxide (LDH)-based nanocomposites is an emerging area in the field of constructing 3-dimensional (3D) hierarchical nanoarchitectures with multiple functionalities. Inorganic LDH compounds, also known as hydrotalcite-like materials or anionic clays, can be found naturally as minerals and can also be readily 
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Dr John Atherton is the Director of Cardiology, Royal Brisbane and Women's Hospital and Associate Professor, The University of Queensland. His research interests include cardiac genetics, heart failure epidemiology and investigating novel methods to detect presymptomatic disease. He sits on the Board of the Cardiac Society of Australia and New Zealand (CSANZ), chairs the CSANZ Professional Ethics Standards Committee, is a member of the National Heart Foundation Heart Failure Guidelines executive writing group, and an appointed member of the Australian Government Medical Services Advisory Committee. He previously chaired the Asia-Pacific Acute Decompensated Heart Failure Registry SAC and the CSANZ Heart Failure Council. synthesised in the laboratory. 8 They consist of hydroxide layers of different metal cations and interlayer spacing occupied by anions and water molecules. 8 At present, LDH nanoparticles can be tailored with the hydrodynamic diameter from 30-40 nm to 5-10 mm using various hydrothermal treatment methods. [9] [10] [11] In addition, through various delamination or top down methods, single-layer LDH nanosheets can be prepared, with the lateral size from 20 nm to several micrometres. 12 Due to their rich ionic surface -OH group and the inherent positive charge, LDH nanoparticles or nanosheets can interact with other nanomaterials or polymeric molecules, generating 3D nanocomposites with particular architectures. We classify LDHbased nanocomposites into four groups, e.g. core@LDH, LDH@shell, dot-coated LDH, and targeting moiety functionalised LDH (Fig. 1 ). In the core-shell structure, the tailorability and functionality of LDH endow LDH with a dual role. LDH can be the shell component that is used to modify other nanoparticles including silica nanoparticles, magnesium ferrite nanoparticles, etc. (Fig. 1A) , and can also be fabricated as the core coated by other nanomaterials, such as the silica shell or the polymeric molecule shell (Fig. 1B) . The dot-coated LDH is a new group of composites with smaller silica or metal nanoparticles being deposited on the surface of LDH (Fig. 1C) . Conjugating antibodies, other biopolymers or folic acid on LDH provides an opportunity for LDH targeting to the site of disease (Fig. 1D) .
With the rapid progress of nanocomposite fabrication, the research focus has been gradually shifted to practical applications with the potential of influencing our daily living conditions. The synthesised nanocomposites often possess the merits and functions of individual components, thus showing advantages over the sole nanomaterial. 13 There are fewer published applications on environment and energy; nevertheless, the nanocomposites including silica@LDH, 14, 15 metal oxide@LDH, 16 LDH@metal, 17, 18 LDH@polymer, 19 folic acid-conjugated LDH, 20 etc., have shown promise as drug delivery vectors, water pollutant removers, high-capacity supercapacitors, and costeffective catalysts.
Tailoring the functions of LDH-related nanocomposites is a relatively new area, yet rapidly evolving area, with a significant increase in the number of publications over the last 10 years (approximately 10-fold annual increase from 2004 to 2013; source from Web of Science). In 2013, Duan and co-workers published a review focusing on the magnetic nanoparticle@LDH core-shell nanostructure. Until now no review paper has comprehensively summarised the basic strategies to construct 3D hierarchical LDH-based nanocomposites and their applications in the fields of biomedicine, environment remediation, and energy conversion and storage. Thus we believe that it is timely to review the latest research progress on hierarchical LDH-based nanocomposites. In this feature article, we summarise the recent advances in design, fabrication and potential applications of LDH-based nanocomposites with a highlight on biomedical applications, and our focus is to link a particular potential application to the hierarchical structure and building components of the corresponding nanocomposites. After a brief review of LDH nanoparticles and nanosheets in terms of concept, synthesis and applications (Section 2), the LDH-based coreshell nanoparticles are reviewed as core@LDH (Section 3) and LDH@shell (Section 4), respectively. The dot-coated LDH nanocomposites and targeting moiety-conjugated LDH nanocomposites for targeted delivery are reviewed in Sections 5 and 6, respectively. In each section, we examine closely the synthesis approaches, structures, and key potential applications. In the final section (Section 7), we provide our perspectives on the future developments in fabrication and application of LDHbased nanocomposites. Various facile synthesis methods have been studied and used to prepare LDH nanoparticles. Co-precipitation and anion exchange are the most common ones in the laboratory and conducted by simultaneously precipitating metal cations at constant or varied pH. The comprehensive study of LDH physicochemical properties and synthesis methods has led to wide applications including drug delivery carriers, 22 biosensors, 23 water treatment agents, 24 catalysts, 25 supercapacitors, 26 etc. Due to the interlayer anions in the LDH gallery being exchangeable, various negatively charged therapeutic molecules and pollutants in wastewaters can be intercalated into the interlayer and adsorbed on the LDH surface, which could allow effective therapy and wastewater treatment, respectively.
LDH nanoparticles and nanosheets

27-29
LDHs containing transition-metal elements are used as supercapacitor electrode materials, because the layered structure of LDHs provides a homogeneous dispersion of transition-metals in the matrix. 30 In recent years, LDH nanosheets are attracting great attention. Thanks to their 2D anisotropy with around one nanometer in thickness and tens to thousands of nanometres in lateral dimension, LDH nanosheets contribute tremendously to fundamental research and their application in building functional nanocomposites. 12 In general, LDH single sheets can be synthesised by two approaches, i.e. delamination of LDH nanoparticles and one-step synthesis of LDH monolayers. 12 Delamination of LDH nanoparticles can be achieved by using a wide variety of solvents, including butanol, acrylates, formamide, etc.; [31] [32] [33] and the one-step synthesis method employs a reverse microemulsion approach. 34, 35 The charged nanosheets can be assembled to produce various nanoconjugates, nanofilms, and nanoarchitectures, which have tremendous potential applications in biomedicine, energy storage and energy conversion.
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Core@LDH nanocomposites
The core@LDH nanocomposites are equipped not only with the unique physicochemical properties (e.g. nanometre size and layered structure), but also with new and interesting functions (e.g. magnetism, porous structure, and high surface-to-volume ratio). We will summarise the synthesis strategy and morphology of the core@LDH nanocomposites, and their applications in drug delivery, water purification, and energy conversion and storage in this section.
Synthesis of the LDH shell
The method of LDH shell synthesis is generally grouped into three categories: (1) coprecipitation; (2) the sol-gel method; and (3) direct deposition (Fig. 3 ). Coprecipitation is a traditional and most commonly used method in the laboratory. The sol-gel method is a new and interesting approach where AlOOH primer sol serves as the substrate as well as the aluminium source. Different from the coprecipitation and the sol-gel method in which LDH grows in situ on the core, direct deposition is conducted by grafting pre-synthesised LDHs on the core surface, and especially useful to fabricate the shell consisting of LDH nanosheets. 3.1.1 Coprecipitation. Coprecipitation is a facile and commonly used method for synthesising the LDH shell. The cores that have been widely studied include silica nanospheres, metal oxide nanoparticles and nanowires, and the shells produced by coprecipitation are always LDH nanoparticles. In general, the core adsorbs two different metal cations that are subsequently precipitated on the surface of the core, and the LDH crystal growth occurs by aging at a certain temperature or through hydrothermal treatment (Fig. 3A) . Zhang et al. used the coprecipitation method to prepare an anti-inflammatory drug-loaded LDH shell on the magnesium ferrite core. 14, 39 In this work, In order to fabricate the homogenous LDH nanostructure on the surface of a ferrite core, pre-coating the core by a thin layer of carbon (C-OH) or silica (SiO 2 ) prior to coprecipitation has been examined (Fig. 3B) . A thin layer of carbon coating by the polymerisation and carbonisation of glucose through a hydrothermal reaction generates large amounts of hydrophilic groups C-OH, which facilitates the formation of the LDH shell on the ferrite core. 42 43 In this method, the boehmite (AlOOH) primer sol prepared by hydrolysing the precursor Al(OPr) 3 was deposited on the scaffold (i.e. paper, cloth or sponge) with several cycles of sol-gel deposition (Fig. 3C) . 43 The generated AlOOH coating as both substrate and source of aluminium resulted in LDH in situ growth on the scaffold (Fig. 3C ). 43 Using this method, Shao et al. successfully synthesised SiO 2 @LDH and Fe 3 O 4 @SiO 2 @LDH core-shell composites with diameters of B600 nm and B900 nm, respectively. 44, 45 Based on the SiO 2 @LDH core-shell structure and the sol-gel method, the same group also synthesised a SiO 2 @LDH yolk-shell and hollow structure by adjusting the concentration of urea. 44 Using the sol-gel method, Wang et al. coated a much smaller SiO 2 core (50 nm, compared with Wei et al.'s 340 nm) with LDH and generated SiO 2 @LDH core-shell nanocomposites. 46 The sol-gel method can also be applied to grow LDH on the carboncoated Fe 3 O 4 , but failed to produce well-dispersed, homogenous core-shell particles. 47 
Direct deposition.
In the direct deposition approach, the core material and LDH nanoparticles or nanosheets are synthesised separately, and subsequent combination of these building blocks generates a core-shell structure by selfassembling, followed by some post-treatment (Fig. 3D) . Ay et al. and Li et al. used the direct deposition method to synthesise magnetic metal oxide core@LDH shell nanocomposites by adsorbing LDH nanoparticles on the core surface. 48, 49 Li et al. also investigated the effect of post-aging temperature on the structure and physicochemical properties of the coreshell nanocomposites. With the temperature increasing from 100 to 160 1C, the LDH particles increased in size and crystallinity, and the morphology of LDH changed from flocculentlike to platelet-like shape. 49 Very interestingly, Choy and co-workers formulated bio core@inorganic shell nanohybrids with a size of around 100 nm by mixing designed DNA solution (negatively charged) and a solution containing LDH nanosheets (positively charged) together. 50 The transmission electron microscopy image of this nanocomposite showed a clear core (biomolecule, e.g. DNA)-shell (LDH) structure with the shell of B10 nm thickness. Nonetheless, accurate control of deposited LDH density remains a challenge. Coating LDH nanosheets on the core sphere via layer-by-layer deposition produces a multi-layered LDH shell in a controlled manner. Sasaki's group fabricated a polystyrene bead@LDH nanosheet core-shell microsphere by depositing 20 layers of poly(sodium 4-styrene sulfonate)-LDH nanosheets. 51 Electrodeposition is a widely applied coating technique in industry to graft one material on the other, and this is also useful to assemble LDH nanoparticles or nanosheets on nanowires. 54 Using this method, LDHs with positive charges are suspended in water and migrate towards the electrode scaffold (i.e. nanowire) under the influence of electrophoresis to construct a 3D hierarchical metal oxide nanowire@LDH nanoarchitecture. 54 
Morphology of core@LDH nanoparticles
In general, the LDH shell in the core-shell nanoarchitectures possesses three different but interactive morphologies, i.e. horizontally oriented platelets, vertically oriented platelets, and mixed platelets (Fig. 4) . The horizontally oriented platelet morphology tends to be formed by direct deposition of LDH nanosheets on the core materials (described in Section 3.1.3) and possibly by coprecipitation (described in Section 3.1.1). 50, 53 The LDH nanosheets have a high aspect ratio, large surface area, and desirable flexibility to be curved, which facilitate the nanosheets to adhere horizontally onto the sphere core. The vertically oriented platelet morphology is an interesting one that creates a porous structure, thus favoured by the researchers in the area of drug delivery and water purification. The LDH shell oriented vertically on the core is often generated by the sol-gel method (described in Section 3.1.2) and sometimes by coprecipitation. 41, 44, 45, 55 The coexistence of horizontally and vertically oriented platelets leads to the formation of the third morphology, i.e. mixed platelets. The mixed platelet morphology was firstly denoted by Zhang et al. who fabricated magnetic core@LDH shell nanocomposites using the coprecipitation method. 14 This type of morphology has been seen in most cases of coprecipitation and direct deposition, 42, 55 and sometimes in the sol-gel method. 46 The linkage between the LDH shell and the metal oxide core has been proposed as MI-O-MII bonds where MI and MII represent metal cations from LDH and the core, respectively. 40, 56 There are two possible interactions between the core and the shell via MI-O-MII bonds: (1) MI-O-MII bonds perpendicular to the LDH layer generate the horizontally oriented LDH shell, and (2) MI-O-MII bonds parallel to the LDH layer form the vertically oriented LDH shell. 40 Zhang et al.
suggested that the vertically oriented LDH morphology is more easily formed because of the more unsaturated sites localised near the edge of LDH layers. 40 However, they did not give explanation for the formation of the horizontally oriented LDH shell. More recently, Chen et al. synthesised Fe 3 O 4 @LDH core-shell nanocomposites with different morphologies by adjusting the methanol/water solvent ratio. 55 They found that the vertically orientated morphology was formed in the water (no methanol) environment, and the mixed morphology formed in the solvent containing methanol and water (volume ratio 1 : 1). 55 In their proposed mechanism, the formation of the former structure, i.e. the vertically oriented LDH, is due to the rapid nucleation of LDH compactly packed on the core surface, simultaneously upon the LDH crystal growth on the (110) plane faster than on the (003) plane. 55 Unfortunately, they did not illustrate the formation mechanism of the mixed morphology. Here, we tentatively propose an assumption to explain the mechanism of different LDH shell morphologies formed by coprecipitation based on the formation mechanism of the vertically oriented LDH on Fe 3 O 4 nanoparticle cores proposed by Chen et al. 55 When nucleation is fast, e.g. high supersaturation, the LDH nuclei are compactly packed on the core surface. Because of the limited growth space, the horizontally oriented nuclei initially formed are sacrificed and subsequently contribute to the crystal growth of the vertically oriented LDHs. Eventually, the vertically oriented LDH shell morphology becomes dominant with the growth along (110) more readily accessible than that along (003) (Fig. 5A ). On the other hand, when the nucleation rate is severely restricted by some factors such as the low supersaturation or solvent, the LDH nuclei are sparsely attached on the core. As the LDH nuclei grow, the relatively smaller vertically oriented LDHs (due to the restriction of growth by the core) are sacrificed, and thus the relatively larger horizontally oriented LDH crystals become dominant (Fig. 5B ). In the situation between these two cases, the mixed platelet morphology forms (Fig. 5C ). To the best of our knowledge, no one reports the horizontally oriented morphology of the LDH shell formed by coprecipitation, while we still suggest the possibility to tailor the morphology of the nanocomposites by properly controlling the nucleation rate based on our assumption. Therefore, synthesis conditions that influence the nucleation rate need to be carefully examined in order to design and fabricate LDHcoated nanocomposites with a specific morphology.
Applications of core@LDH nanocomposites
Owing to their unique properties such as high surface area, magnetism and porous structure, the core@LDH nanocomposites have been examined for their application in drug delivery, water purification, and energy conversion and storage. 3.3.1 Drug delivery. Drug delivery, as one of the most important applications of functional core@LDH nanocomposites, allows ideally sustained, controlled, and/or targeted delivery of therapeutic compounds with the aim of improving their therapeutic effects. The core provides a matrix for the shell growth, and more importantly endows the nanocomposite with extra functional properties, such as ferric magnetism and superparamagnetism. The LDH shell serves as an efficient drug host by intercalating/releasing the drug/gene anions into/from the LDH interlayer, 27, 57, 58 the LDH shell by diffusing from the LDH interlayer and/or by LDH layer dissolution, and the drug/gene release from the composites always shows a sustained release profile, in which an initial burst release can quickly establish the therapeutic dose and the subsequent prolonged release maintains this dose for a long period of time.
The drugs intercalated in the LDH shell include antiinflammatory drugs (e.g. diclofenac, ibuprofen, and glucuronic acid), 14, 56, 58 anti-cancer drugs (e.g. doxorubicin, doxifluridine, and 5-fluorouracil), 41, 42, 49 and hepatitis B virus DNA vaccine. 46 Wang et al. synthesised SiO 2 @LDH nanocomposites with an average diameter of 210 nm and mixed platelet morphology. 46 They claimed that the most important advantage of this nanocomposite over other nanomaterials was its larger surface area, which could allow the loading and delivery of a large amount of DNA vaccine. 46 They also found that DNA vaccine loadedSiO 2 @LDH immunised mice demonstrated much higher serum antibody response than naked DNA vaccine, and enhanced T-cell proliferation and skewed T helper to Th1 polarisation. 46 In the physiological environment, the loaded drugs are released in a sustained manner from the nanocomposites by anion exchange and/or nanocomposite biodegradation. 27 Zhang et al. designed a controlled drug release device by coprecipitating the mixed platelet LDH shell with diclofenac loading on the magnesium ferrite nanoparticle core (Fig. 6A) . 14 Under an external magnetic field, they observed a decreased drug release rate (B20% decrease) in pH 7.45 phosphate buffer saline (PBS), which is presumably resulted from the aggregation of the magnetic nanocomposites triggered by magnetic force (Fig. 6B and C) . 14, 39 This group also claimed that the overall release profile was determined by three diffusion paths of the loaded drug from the magnetic nanohybrids ( Fig. 6D ): (I) intraparticle diffusion from the LDH interlayer space to the LDH interparticle space, (II) interparticle diffusion from the space among the LDH particles to the inter-aggregate space, and (III) inter-aggregate diffusion from the space among the core-shell particle aggregation to solution. 14 When the magnetic field was applied, the magnetic core-shell nanohybrids aggregated, leading to longer diffusion length, higher diffusion resistance, and a decreased drug release rate (Path III) (Fig. 6B and D) . 14, 39 Apart from the controlled release, targeted delivery of drugs to the diseased site using the magnetic core-shell nanohybrids is also promising with the application of an external magnetic field. 58 The magnetic drug delivery system concentrates the drug dosage at a target site with the aid of an external magnetic field, thus avoids nonspecific drug delivery, enhances the therapeutic effect and reduces the drug side effects. 59, 60 The targeted delivery can also be achieved by conjugating antibody and other ligands on the LDH nanoparticles, 49 ,61 and will be described in detail in Section 6. Chen et al. reported a typical vertically oriented SiO 2 @LDH core-shell nanocomposite synthesised by ultrasound-assisted coprecipitation (Fig. 7A) , which showed much more efficient adsorption of diclofenac (a typical pharmaceutical pollutant) than LDH aggregates in terms of the adsorption rate and capacity (Fig. 7B) . 15 They found that the higher adsorption capacity of diclofenac on this core-shell nanocomposite (758 mg g À1 ) than that on LDH aggregates (489 mg g À1 ) was mainly related to the large surface area of the vertically oriented LDH shell (Fig. 7B) . 15, 64 The adsorption capacity of diclofenac by SiO 2 @LDH (758 mg g À1 ) is also obviously higher than that by polymers (324.8 mg g À1 ) 64 and mesoporous silica (0.34 mg g
À1
). 65 The magnetic nanoparticle@LDH core-shell nanocomposites have also been synthesised to remove fluoride ions and uranium(VI) from aqueous solutions. 16, 47 After pollutant adsorption, regeneration and re-utilisation of the spent adsorbents is a vital process in large-scale costeffective wastewater treatment. The feasible and efficient approaches to regenerating core@LDH nanohybrid adsorbents include (1) advanced oxidation to decompose the adsorbed compounds and (2) desorption of the pollutant in the eluent to re-use. 15, 16, 47, 66 With advanced oxidation, Chen et al.
reported the removal efficiency of SiO 2 @LDH being consistently above 90% for at least four runs by using Co 2+ ions and ozone as the catalyst and oxidant, respectively (Fig. 7C) . 15 The desorption efficiency is dependent on the affinity of intercalated anions in the LDH-based adsorbent and the anions in the eluent. In general, the eluent containing CO 3 2À had the highest desorption efficiency of around 80%. 16, 47 3.3.3 Energy conversion and storage. Many efforts have been made to develop efficient and sustainable energy storage and conversion approaches because of ever worsening energy depletion and global warming. [67] [68] [69] The core@LDH nanocomposites with enhanced supercapacitor and catalyst behaviour can be potentially applied in energy storage and conversion devices. 56 The characteristic properties of a supercapacitor candidate include high redox activity, high surface area, and suitable mesopore/micropore size distribution. Researchers have found that the synthesised 3D hierarchical core@LDH architectures possess these properties, and show excellent supercapacitive performance in terms of capacitance, energy density, and the cycling rate. 44, 54, 70 With different synthesis methods applied (such as deposition and sol-gel), these core@LDH architectures always have vertically orientated or mixed platelet morphology which allows the nanocomposite to form porous structure and enlarge the surface area to the maximum extent. 44, 54, 70 The different interior hierarchy structures (SiO 2 @LDH core-shell, yolk-shell, and hollow LDH shell) have also been compared in their supercapacitive performance. Shao et al. showed that the hollow NiAl-LDH structure had greatly improved faradaic redox reaction and mass transfer, and exhibited excellent pseudocapacitance performance because of the large surface area of the hollow structure, which provides effective diffusion channels for the electrolyte ions. 44 ). 76 This new hierarchical structure shows as a highly promising electrode that can be applied in electrochemical energy storage. 71 In addition to supercapacitors, core@LDH has been studied as a catalyst to convert acetone to diacetone alcohol as an alternative fuel component at the thermodynamic equilibrium with the conversion of 23% at 273 K. 56 The authors claimed that the catalyst was easily recovered attributed to the magnetic core and reactivity in the second run remained unchanged. 56 
Other applications.
Other applications of the core@LDH nanocomposites include immunosensors, 61 a DNA-based document ID system, 50 and purification of recombinant proteins. 45 Fewer studies in these interesting areas may imply that more efforts should be directed into these applications.
LDH@shell nanocomposites
Continuous efforts have been dedicated to producing the shell of different matters on the LDH core for application in healthcare, energy conversion and storage. The functionalisation methods, including adsorption, polymerisation, etc., take advantages of LDH surface -OH groups and its surface positive charge. Thanks to the successful innovation of these methods, a variety of functional nanomaterials (i.e. silica nanoparticles, polymers, and proteins) and small molecules (i.e. surfactant and folic acid) have been anchored on the LDH core to form various LDH@shell nanocomposites. This kind of combination can be regarded as the surface modification of LDH nanoparticles to improve LDHs' functionality, and also viewed as combining the advantages and functions of the LDHs and the functional nanomaterials for their practical applications, such as drug delivery, imaging, catalysis, and energy storage, as summarised in this section.
LDH@SiO 2
To encapsulate LDH with SiO 2 to form LDH@SiO 2 nanorattles, tetraethyl orthosilicate Si(OC 2 H 5 ) 4 (TEOS) is used as the source of silica, and hydrolysed on the surface of the LDH core (as a nuclear). The linkage between these two inorganic nanomaterials (LDH and SiO 2 ) is suggested to be -M-O-Si-(M is the metal cation in the brucite-like layer of LDH), as illustrated in Fig. 8 . 
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In 2011, Zhao's group synthesised a novel uniform coreshell nanostructure with LDH as the core and ordered mesoporous silica as the shell. 77 The morphology of this core-shell nanocomposite observed under TEM is interesting, showing two types of nanostructures ( Fig. 9A): (1) mesoporous nanoplates, and (2) rod-like cores covered by ordered mesoporous silica. 77 These two nanostructures are suggested to be projections of LDH@SiO 2 nanocomposites from two perpendicular directions (Fig. 9A) . 77 By adjusting the amount of TEOS, the average thickness of the mesoporous silica shell could be tuned between 20 and 50 nm. 77 The LDH@SiO 2 nanocomposites retain the properties of both LDH and SiO 2 , including high drug loading capacity, dispersivity and biocompatibility, sustained release of anionic drugs, and ready surface modification. 77 Meanwhile, Liu et al. synthesised a LDH@SiO 2 nanostructure for drug delivery (Fig. 9B) . 78 Although the particles were less controllable in morphology compared with Zhao group's work, they still showed sustained release of the drug and other important properties for drug delivery. 78 Apart from being a drug carrier, 79,80 the LDH@SiO 2 nanocomposite has been investigated as a catalyst precursor. 81 Shi's group fabricated a multi-nanoparticle-embedded core@ mesoporous silica shell structure. 81 The core consisted of aluminium/magnesium oxides (that were then converted to LDH) and Au nanoparticles, in which the aluminium/ magnesium oxides provided an essential support for Au nanoparticles, and the mesoporous silica shell offered the diffusion channels for reactants and products, allowing efficient access of reactants to the catalytic nanoparticles inside. 81 
LDH@protein
Protein is an amphiphilic biopolymer, and its interactions with LDH nanoparticles provide a new way to stabilise the colloidal stability, and moreover, to deliver protein/peptidebased drugs. There are a few investigations on the interactions between LDH nanoparticles and various proteins. An et al.
assembled protein-adsorbed LDH nanosheets in HCl-Tris buffer, and studied the conformations and orientations of three adsorbed proteins (porcine pancreatic lipase (PPL), haemoglobin (Hb), and bovine serum albumin (BSA)) (Fig. 10) . 82 The structure and conformations of PPL were well retained because of negative charges concentrated on the side opposite to the active centres, and the orientations of PPL could be lying flat or standing up depending on the ratio of PPL and LDH (Fig. 10a) . The bioactivity of PPL was thus enhanced in the hydrolysis and kinetic resolution in comparison with its soluble counterpart. The secondary structure and redox-active heme groups of Hb were not denatured either, but its tertiary or quaternary structure was changed through unfolding (Fig. 10b) . The negative charges on the BSA surface were distributed along the linearly arranged domain I and II, resulting in the unfolded secondary structure (Fig. 10c) . Therefore, the conformation and orientation of proteins on LDH nanosheets are dependent on the charge distribution and structural features of the proteins. These authors further suggested that the LDH nanosheet could improve the activity and stereoselectivity of at least some lipases. 82 Kong et al. reported the assembled LDH nanosheets with Hb and horseradish peroxidase via the layer by layer deposition technique. They found that the assembled protein/LDH electrode showed remarkable electrocatalytic activity towards oxidation of catechol in a wide linear response range, a low detection limit, high stability and reproducibility. 83 Bellezza et al. observed that proteins (myoglobin and BSA) strongly interacted with NiAl-LDH or NiCr-LDH nanoparticles and exhibited a Langmuir-type adsorption. 84, 85 Our group also constructed the LDH nanocomposites with ovalbumin (OVA) (Fig. 11A) and BSA coating to modulate immune response and improve LDH stability, respectively. 86, 87 The adsorption of OVA and BSA on LDH nanoparticles was well fitted with the Langmuir model ( Fig. 11B and C) ; the maximum monolayer adsorption capacity was 0.58 mg mg À1 for OVA (Fig. 11B) , 86 and 0.70 mg mg À1 for BSA (Fig. 11C ) on 110 nm LDH nanoparticles. 87 Coating OVA on LDH demonstrated that LDH as an adjuvant induced a high level of IgG1 antibodies comparable to Alum (an FDA approved adjuvant for human vaccination) but with much weaker inflammation. 86 BSA pre-coating prevented LDH 
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and drug/gene-loaded LDH from aggregation in the electrolyte solution (physiological environment) and enhanced the cellular uptake, possibly due to the improved colloidal stability of nanoparticles in the culture medium solution. 87 
LDH@polymer
There are two main methods to functionalise LDH nanoparticles with polymers: (1) adsorption of pre-synthesised polymers via electrostatic interaction, 19, [88] [89] [90] (2) in situ polymerisation, including one-pot in situ polymerisation, 91 surfaceinitiated atom transfer radical polymerisation (ATPR), 92, 93 and crosslinking. 94 Adsorption of anionic polymers on the LDH surface can be achieved by simply mixing the two components or via electrodeposition. This synthesis method takes advantages of the positive charge on the LDH surface, thus the conjugated polymers are required to be negatively charged. Because of its facile procedure, adsorption is the most common method used to synthesise LDH@polymer nanocomposites. One-pot in situ polymerisation uses LDH nanoparticles as the template/core to polymerise the anionic monomers, without washing and transferring steps. In this method, the monomer is often anchored on the LDH core via electrostatic attraction. The surface-initiated ATPR originates from the atom transfer step, which allows uniform growth of the polymeric chains. 95 Moreover, the ATPR reaction can be achieved under environmentally friendly conditions using water as the solvent. 96 Cross-linking is usually achieved by covalently cross-linking polymers that are adsorbed on the LDH surface via a crosslinked agent (e.g. glutaraldehyde). 94 The main application of LDH@polymer nanocomposites is drug/gene delivery. Hu et al. tailored the functionality of LDH surfaces through surface-initiated ATPR of 2-(dimethylamino)-ethyl methacrylates. 93 This LDH composite with the flexible polycation brushes (2-(dimethylamino)-ethyl methacrylates) demonstrated increased ability to condense plasmid DNA, and higher cellular uptake and gene transfection efficiency in COS7 and HepG2 cell lines. 93 Poly(ethylene glycol) (PEG) is considered a biocompatible polymer, and widely used to functionalise other drug delivery carriers with the aim of increasing colloidal stability and circulation time. [97] [98] [99] For example, Li et al. synthesised anionic PEG functionalised LDH nanohybrids. 90 This LDH@PEG nanohybrid displayed enhanced colloidal stability and re-dispersing ability compared with LDH itself, due to the polymer steric hindrance and the electrostatic repulsion. 90 Colonic delivery is the other important area of LDH@polymer application. In order to improve the mucoadhesive ability and controlled release in acidic environments, the drug carrier LDH is coated with Eudragit or pectin to enhance the structural integrity in the acidic environment. 88, [100] [101] [102] [103] The LDH@polymer is also applied for high-performance energy storage. Han et al. fabricated a LDH@poly(3,4-ethylenedioxythiophene) (PEDOT) core-shell nanoplatelet array (NPA) grown on a flexible Ni foil substrate as a high performance pseudocapacitor (Fig. 12A) , in which the LDH core provided high energy storage capacity, and the polymer shell and its porous structure facilitated electron/mass transport in the redox reaction. 19 The LDH@PEDOT core-shell NPA showed a maximum specific capacitance of 649 F g À1 by cyclic voltammetry (scan rate was 2 mV s À1 ) and 672 F g À1 by galvanostatic discharge (current density was 1 A g À1 ) ( Fig. 12B and C) . 19 The specific capacitance of the well-arranged LDH@PEDOT NPA (672 F g
À1
) was much higher than its counterpart LDH@ PEDOT-Ni foam (334 F g À1 ), indicating that the mesoporous and well-ordered structure enhances ion diffusion of the electrolyte and electron transfer. 
LDH@organic hydrophobic modifier
Different from polymers, the organic modifiers with much smaller molecular weight are anchored on the LDH surface with the aim of modifying LDH's intrinsic hydrophilic properties.
The organic modifiers include various surfactants (such as sodium dodecyl sulphate, dodecylsulfonate, and dodecylbenzenesulfonate) and other anionic organic molecules (hexanoic acid and silane coupling agents). 89, [104] [105] [106] [107] [108] Hydrophobic modification of LDH is applied in drug delivery of hydrophobic pesticides and dyes, 106, 107 as well as in biofuel production. 105, 108 It is worth noting that some of the organic modifiers are not only anchored on the surface of the LDH matrix, but also intercalated in the LDH gallery space, and the ionic affinity of the molecules may allow partial exchange of anions between LDH layers.
Dot-coated LDH nanocomposites
Recently, dot-coated LDH nanocomposites as a group of new hierarchical hybrid materials have attracted interest. The dot-coated LDH consists of an LDH substrate and other smaller sphere-shaped nanodots coated on the surface of LDH (Fig. 1C) . Different from the LDH@shell nanocomposites, the surface of LDH is only partly covered by coated dots, thus presenting a new hierarchical structure of LDH nanocomposites and exhibiting some exciting advantages, such as the possibility of multi-functionalising LDH. Moreover, the increased particle surface roughness could also enhance cell binding and subsequent engulfment by cells in biomedical applications. 109 The coating nanomaterials that have been developed include metal nanoparticles (e.g. Au nanoparticles, Pd nanoparticles, and Ag nanoparticles) and SiO 2 nanoparticles, 17, 18, 110, 111 and the synthesised dot-coated LDHs have been examined in drug delivery and simultaneous bio-imaging, and catalysis.
Metal nanoparticle dot-coated LDH
Shi's group reported Gd-doped LDH@Au nanocomposites to dually function as a drug carrier and a diagnostic agent. 18 As claimed by the authors, the advantage of this nanocomposite over other nano-systems is that the imaging agents (i.e. Gd 3+ and Au nanoparticles) can be easily and effectively introduced into LDH and thus form the unique dot-coated nanocomposite structure. In this structure, Gd 3+ as the magnetic resonance imaging contrast agent was doped in the LDH lattice via the coprecipitation method, and Au nanoparticles with an average diameter of 3.4 nm were incorporated in the nanocomposite by depositing Au(OH) 3 on the surface of LDH under alkaline conditions, followed by the reduction with NaBH 4 ( Fig. 13A and B) . 18 This LDH-Gd@Au nanocomposite had an average hydrodynamic diameter of around 140 nm, and was well-dispersed in water (Fig. 13C) . 18 By culturing mouse fibroblastic cell lines and human cervical cancer cell lines in vitro, the authors showed enhanced doxorubicin delivery efficiency with LDH-Gd@Au compared with free doxorubicin (Fig. 13D) . 18 Meanwhile, thanks to the component of Gd 3+ and Au, the LDH-Gd@Au nanocomposite acted efficiently as a dual-functional contrast agent for magnetic resonance imaging and X-ray computed tomography imaging in a tumour-bearing mice model (Fig. 13E) . 18 Zhao et al. anchored finely dispersed Pd nanodots (B1.8 nm) to CoAl-LDH nanoparticles (B1.5 mm) via a facile in situ redox reaction between the Co 2+ in LDH nanoparticles and the PdCl 4 2À precursor. 17 This architecture showed enhanced catalytic activity and robust durability towards ethanol electro-oxidation compared with the commercial Pd/C catalyst, in which LDH played a ternary role: a catalyst support, a stabiliser of Pd nanodots, and a reducing agent (without any external agent). 17 Zhao et al. claimed that this work provided a promising approach to fabricating highly efficient nanocatalysts that could be used in fuel cells and other related catalytic reactions. 17 Apart from these two examples in biomedical and catalytic applications, metal nanoparticles, such as Ag nanoparticles and quantum dots, have also been dot-coated onto the surface of LDH and investigated in the field of sterilisation and light emitting diodes. 110, 112, 113 
SiO 2 nanoparticle dot-coated LDH
Our group recently synthesised amine-functionalised SiO 2 dotcoated LDH (LDH@SiO 2 -NH 2 ) nanocomposites via electrostatic interactions and condensation of APTES (Fig. 14a) . 111 This synthesis strategy is different from the one for LDH@SiO 2 discussed in Section 4.1, with the purpose of fabricating the dot-coated nanostructure instead of the core-shell structure. SiO 2 nanodots (Z-average size of 10-15 nm, zeta potential of Feature Article ChemComm À38.8 mV) and LDH nanoparticles (approximately 110 nm, +42.5 mV) were synthesised separately, and then mixed to form LDH@SiO 2 nanocomposites via electrostatic attraction. 111 The nanocomposites were modified with -NH 2 by condensing APTES on the surface.
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The resulted LDH@SiO 2 -NH 2 had the average hydrodynamic diameter of 256 nm, and showed uniform SiO 2 nanodots of around 10-15 nm attached on the surface of LDH (Fig. 14b-g ). 111 The amine-functionalised SiO 2 dotcoating improved LDH dispersion in the culture medium and PBS, and more importantly enhanced siRNA delivery to the U2OS cell line to inhibit cell proliferation, probably due to the improved nanoparticle dispersion. 111 We also suggest that the enhanced endosomal escape increases cell death, 111 in comparison with the positively charged silica nanoparticles, 114 which seems to be less capable for the proton sponge effect.
LDH@targeting moiety
There are numerous barriers for nanoparticle-based drug carriers en route to their target, such as mucosal barriers and non-specific uptake. [115] [116] [117] Thus it is necessary to combine the rational design of nanocarriers with moieties to encourage active targeting. This may also allow a more favourable benefit-risk profile by reducing organ toxicity, which often limits the clinical effectiveness of anthracyclines. Indeed, as tumour-free survival improves with novel chemotherapeutics, their impact of overall survival is often limited by organ toxicity, which could be potentially mitigated by nanocomposite-based drug delivery. 118 In the case of LDH nanocarriers, recent progress in targeting moiety design has been seen in conjugating folic acid and antibody agents. 20, 57, [119] [120] [121] Folic acid has a high affinity (K d E 100 pM) for folate receptors which are often overexpressed in various human cancers, such as ovary, lung, kidney, colon cancer, etc.
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By conjugating this cancer cell specific ligand on LDHs, Choy's group described the selectivity of this nanohybrid to folate receptor-overexpressed cell lines (i.e. human nasopharyngeal epidermoid carcinoma cells) in comparison with folate receptor deficient cell lines (i.e. human lung adenocarcinoma epithelial cells). 20 It is worth noting that the anionic type of folic acid can be intercalated into the LDH gallery space, which may result in the targeting function of folic acid being shielded. [126] [127] [128] To address this issue, the researchers from the same group grafted folic acid on the surface of LDH by covalent coupling using silane coupling reagents APTES and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC). 20 To do this, the surface of LDH nanoparticles was modified with APTES, whose amine end group could be conjugated with the functional groups such as carboxylate and thiocyanate. 20 For example, the activated carboxyl group of folic acid by N-hydroxysuccinimide, using EDC as a coupling agent, was then combined with the amine end group of APTES on the surface of LDH to form LDH@folic acid composites. 20 To target vascular injury caused by surgical treatment (e.g. angioplasty), our group conjugated anti-coagulant drug low molecular weight heparin (LMWH)-intercalated LDH nanoparticles with a cross-linked fibrin antibody (an antibody that rapidly accumulates at the site of vascular injury and remains for many weeks) by associating the sulfhydryl-modified antibody with the maleimide-containing LMWH. 121, [129] [130] [131] With this LMWH-LDH@antibody, we observed specific delivery of drugs to the site of injury, reduced luminal loss and thrombotic occlusion in a rat model of arterial injury. 121 
Conclusions and perspective
This feature article summarises the recent progress in synthesis approaches, physicochemical properties, and potential applications of LDH-based nanocomposites. The hierarchical LDH nanocomposites, combining the advantages of LDH nanoparticles/nanosheets and other nanomaterials/molecules, do not only show the advantages over each component of the nanocomposites, but also show some superiority to other nanomaterials such as polymers, metal oxide and mesoporous silica nanoparticles, when they are applied in drug delivery, imaging, water purification, catalysis, and energy storage. Some exciting research contributions are highlighted in this feature article to illustrate the unique structures, excellent properties, and important applications of the hierarchical LDH nanocomposites. In particular, the synthesis and application of dot-coated LDH nanocomposites is a new and emerging area, and worthy of further investigation, due to the virus-like surface of dot-coated LDH nanocomposites and the availability for multi-functionalisation. Although there have been rapid advances in the synthesis and application studies of LDH-based nanocomposites, it is still a newly emerging area and there is a great deal of room for researchers to explore in this area. Constructing a new hierarchical structure will not only provide a new conceptual structure and synthesis approach, but will also offer an opportunity for potential applications. When an LDH-based nanocomposite is designed and synthesised, it is a priority question to consider whether the nanocomposite takes full use of LDH and other nanomaterials. By fabricating LDHs with different metal cations and anions, LDH could be a candidate to be used for different modes of bio-imaging as contrast agents, production of a number of compounds as catalysts, and delivery of various therapeutic molecules.
Towards the final goal of transferring LDH-based nanocomposites from bench to industry, there are several challenges to address. One of the major challenges is to simplify the synthesis process with precise control of particle size and morphology. This is also the prerequisite for scale-up. For LDH-based nanocomposites to be used in clinics, the colloidal stability of the nanocomposites also needs to be considered, as the aggregated particles would lower the therapeutic efficacy or even block the blood vessel to cause the clot eventually. The lack of bio-safety and the bio-distribution profile for healthcare application is another challenge. Future research should focus on closely linking up the nanocomposite physicochemical properties with practical applications, including, but not limited to, therapeutics, diagnosis, water and air purification, energy storage, and energy conversion.
